1h Free Analyst Time
Global Monoclonal Antibodies Market 2021-2025Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the monoclonal antibodies market and it is poised to grow by $ 63.41 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. The report on monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the introduction of low-priced biosimilar monoclonal antibodies and targeted therapeutic mechanism of action. In addition, introduction of low-priced biosimilar monoclonal antibodies is anticipated to boost the growth of the market as well.
The monoclonal antibodies market analysis includes application segment and geographical landscapes.
The monoclonal antibodies market is segmented as below:
By Application
- Oncology
- Autoimmune disorders
- Infectious diseases
- Other applications
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the strong R&D pipeline as one of the prime reasons driving the monoclonal antibodies market growth during the next few years.
The report on monoclonal antibodies market covers the following areas:
- Monoclonal antibodies market sizing
- Monoclonal antibodies market forecast
- Monoclonal antibodies market industry analysis
The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading monoclonal antibodies market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the monoclonal antibodies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by Type
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global monoclonal antibodies market: AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing cases of diseases like cancer and immunological disorders.'
According to the report, one of the major drivers for this market is the introduction of low-priced biosimilar monoclonal antibodies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
